Pura Vida Investments, LLC Novo Cure LTD Call Options Transaction History

Pura Vida Investments, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2020 Nov 16, 2020	SELL	$58.05 - $111.31 $3.22 Million - $6.17 Million	-55,400 Closed	0 $0
Q2 2020 Feb 12, 2021	BUY	$57.2 - $74.41 $3.14 Million - $4.08 Million	54,846 Added 9900.0%	55,400 $3.29 Million
Q2 2020 Aug 14, 2020	SELL	$57.2 - $74.41 $3.08 Million - $4.01 Million	-53,846 Reduced 98.98%	554 $15,000
Q1 2020 Feb 12, 2021	BUY	$57.05 - $95.75 $3.07 Million - $5.16 Million	53,856 Added 9900.0%	54,400 $3.66 Million
Q1 2020 May 15, 2020	BUY	$57.05 - $95.75 $31,035 - $52,088	544 New	544 $137,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.